{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:13Z","timestamp":1789473913545,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.eucr.2026.103561","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:48:51Z","timestamp":1785167331000},"page":"103561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ipsilateral adrenal metastasis with adrenal and residual renal vein tumor thrombus from ESC-RCC 6 years post-nephrectomy: A case report"],"prefix":"10.1016","volume":"68","author":[{"given":"Longchao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eucr.2026.103561_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and Male genital organs-part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.eucr.2026.103561_bib2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.eucr.2026.103561_bib3","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.eucr.2026.103561_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115982","article-title":"Eosinophilic solid and cystic renal cell Carcinoma-A systematic review and meta-analysis","volume":"25","author":"Loghin","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.eucr.2026.103561_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2013.08.019","volume":"50","author":"Aitchison","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.eucr.2026.103561_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bjc.6602443","article-title":"Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)","volume":"92","author":"Atzpodien","year":"2005","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.eucr.2026.103561_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1470-2045(22)00487-9","article-title":"Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Powles","year":"2022","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.eucr.2026.103561_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","article-title":"Overall survival with adjuvant pembrolizumab in renal-cell carcinoma","volume":"390","author":"Choueiri","year":"2024","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.eucr.2026.103561_bib9","first-page":"3885","article-title":"Investigation on the indication of ipsilateral adrenalectomy in radical nephrectomy: a meta-analysis","volume":"125","author":"Su","year":"2012","journal-title":"Chin Med J"},{"issue":"4","key":"10.1016\/j.eucr.2026.103561_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040763","article-title":"Adrenalectomy for metastasis: the impact of primary histology on survival outcome","volume":"16","author":"Ferriero","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.eucr.2026.103561_bib11","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s12672-025-04160-0","article-title":"Survival outcomes and prognostic predictors after adrenalectomy for renal cell carcinoma adrenal metastasis","volume":"16","author":"Han","year":"2025","journal-title":"Discov Oncol"},{"issue":"14","key":"10.1016\/j.eucr.2026.103561_bib12","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/1078-0432.CCR-20-4548","article-title":"Phase II clinical trial of everolimus in a pan-cancer cohort of patients with mTOR pathway alterations","volume":"27","author":"Adib","year":"2021","journal-title":"Clin Cancer Res : Off J Am Associat Cancer Res"},{"issue":"1","key":"10.1016\/j.eucr.2026.103561_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOU.0000000000001229","article-title":"Adjuvant treatment for renal cell carcinoma: current status and future","volume":"35","author":"Leung","year":"2025","journal-title":"Curr Opin Urol"},{"issue":"5","key":"10.1016\/j.eucr.2026.103561_bib14","first-page":"458","article-title":"The 2022 updated European association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma","volume":"82","author":"Bedke","year":"2022","journal-title":"Eur Urol"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221444202600224X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221444202600224X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:33:54Z","timestamp":1789472034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221444202600224X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"alternative-id":["S221444202600224X"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103561","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ipsilateral adrenal metastasis with adrenal and residual renal vein tumor thrombus from ESC-RCC 6 years post-nephrectomy: A case report","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103561"}}